Volume | 14,268 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.56 | Mínimo Máximo |
|||||
Minimo del Dia | 2.38 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Incannex Healthcare Ltd | IXHL | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.51 | 2.38 | 2.56 | 2.39 | 2.55 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
212 | 14,268 | US$ 2.48 | US$ 35,389 | - | 0.80 - 12.68 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:25:31 | 49 | US$ 2.3806 | USD |
Información Financiera Incannex Healthcare Ltd IXHL
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
793.66k | 15.87M | - | 1.01M | -19.98M | -1.26 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Incannex Healthcare Ltd IXHL
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
16/4/2024 | 07:00 | GlobeNewswire Inc. | Incannex Healthcare Inc. Quarterly Update, Q1 2024 |
28/2/2024 | 06:30 | GlobeNewswire Inc. | Incannex Announces Positive Topline Results from Phase 2.. |
16/2/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 06:30 | GlobeNewswire Inc. | Incannex Completes Successful Pre-IND Meeting with the FDA.. |
14/2/2024 | 05:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
01/2/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
01/2/2024 | 06:30 | GlobeNewswire Inc. | Clarion Clinics Open for Psychedelic-Assisted Treatments |
24/1/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 15:05 | GlobeNewswire Inc. | Incannex Commences Dosing in Phase 2 Clinical Trial.. |
18/1/2024 | 08:08 | Edgar (US Regulatory) | Form 8-K - Current report |
18/1/2024 | 07:22 | GlobeNewswire Inc. | Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD”.. |
17/1/2024 | 06:30 | GlobeNewswire Inc. | Incannex Receives IRB Approval for the RePOSA Phase 2/3.. |
Histórico de Datos IXHL
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.23 | 2.94 | 2.20 | 2.64 | 19,507 | 0.16 | 7.17% |
1 Month | 3.4278 | 3.435 | 2.13 | 2.70 | 19,325 | -1.04 | -30.28% |
3 Months | 3.28 | 8.4697 | 2.13 | 5.71 | 339,360 | -0.89 | -27.13% |
6 Months | 1.07 | 12.68 | 0.80 | 5.85 | 197,690 | 1.32 | 123.36% |
1 Year | 2.00 | 12.68 | 0.80 | 4.88 | 130,926 | 0.39 | 19.50% |
3 Years | 11.00 | 90.00 | 0.80 | 7.23 | 90,109 | -8.61 | -78.27% |
5 Years | 11.00 | 90.00 | 0.80 | 7.23 | 90,109 | -8.61 | -78.27% |